OlinHuntsman merger: Olin (NYSE: OLI) to combine with Huntsman (HUN) in all-stock deal
Rhea-AI Filing Summary
Olin and Huntsman announced an all-stock merger of equals to form OlinHuntsman Corporation, creating a combined company with >$12 billion in pro forma 2025 revenue. Huntsman shareholders will receive 0.5476 Olin shares per Huntsman share, leaving Olin holders with ~54.5% and Huntsman holders with ~45.5% of the combined company.
The companies expect >$400 million of cost synergies and integration benefits (including ~$300 million achievable within 24 months and an additional ~$100 million tied to 2031 contract expirations). Pro forma adjusted EBITDA is shown at ~$1.3 billion including synergies; pro forma net leverage is estimated at 4.6x year-end 2025 (approx. 3.2x with full synergy implementation). The transaction is expected to close in H1 2027, subject to regulatory and shareholder approvals.
Positive
- None.
Negative
- None.
Insights
Merger combines upstream chlorine/caustic scale with downstream specialty capabilities.
The announced all-stock merger creates a vertically integrated chemicals platform linking Olin’s chlor-alkali and feedstock positions with Huntsman’s downstream polyurethanes, amines and advanced materials. The companies present a quantified synergy case: >$400M total, ~ $300M expected early and $100M tied to contract expirations in 2031.
Key dependencies include regulatory approvals, successful integration execution, and realization of procurement and operations synergies. Subsequent filings (the Form S-4/joint proxy) will provide transaction mechanics, governance and dilution detail.
Pro forma leverage and cash flow priorities center on deleveraging and disciplined capital allocation.
On a 2025 pro forma basis the presentation cites ~$12.5B revenue and ~$1.3B adjusted EBITDA including synergies. Management highlights pro forma net leverage of 4.6x (year-end 2025) or ~3.2x post-synergies, a blended cost of debt ~5%, and maintenance capex of ~$400M per year.
Planned initial cash priorities are deleveraging, maintaining a stable dividend, and funding high-return growth. Realized cash-tax benefits from NOL acceleration (~$125M) are disclosed separately from synergy totals.